Having trouble accessing articles? Reset your cache.

rhCIII: Phase I data

In a Phase I trial in 10 patients with corneal disease, 100%

Read the full 128 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE